Nurse Practitioner, Adult Health · Brooklyn, NY
NPI
1871655977
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
2995 Ocean Pkwy
Brooklyn, NY, 11235
Phone (718) 975-4330
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
1,127 services
Medicare patients, 2024
243
Average age 79
Drug cost, 2024
$6.3M
8,748 prescriptions
Company payments, 2025
$1,796
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marina Kurman was code 99213 (office e&m - established), 188 times for 118 patients. In total Marina Kurman billed 1,127 services in 27 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 188 | 118 | $64.68 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 93 | 75 | $40.41 | $3,758 |
| 99203 Office E&M - New | Office | 73 | 73 | $78.12 | $5,703 |
| 99442 Telephone Services | Office | 26 | 24 | $55.10 | $1,433 |
| 99212 Office E&M - Established | Office | 16 | 14 | $41.25 | $660 |
| 96372 Injection Administration | Office | 14 | 11 | $8.68 | $121 |
By year: 2022 $48K for 1,011 services; 2023 $27K for 975 services; 2024 $27K for 1,127 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marina Kurman prescribed most often to Medicare patients was Ubrelvy (Ubrogepant), with 493 prescriptions and refills. In total Marina Kurman wrote 8,748 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ubrelvy Ubrogepant | 493 | 493 | 57 | $740K |
| Nurtec Odt Rimegepant Sulfate | 362 | 362 | 43 | $673K |
| Linzess Linaclotide | 285 | 289 | 41 | $149K |
| Xifaxan Rifaximin | 261 | 261 | 27 | $621K |
| Diclofenac Sodium Generic | 242 | 242 | 45 | $171K |
| Xiidra Lifitegrast | 241 | 244 | 32 | $160K |
| Vascepa Icosapent Ethyl | 228 | 240 | 40 | $81K |
| Amlodipine Besylate Generic | 222 | 280 | 47 | $387 |
| Rosuvastatin Calcium Generic | 211 | 259 | 43 | $875 |
| Jublia Efinaconazole | 200 | 202 | 32 | $278K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 198 | 206 | 27 | $119K |
| Zenpep Lipase/Protease/Amylase | 197 | 198 | 29 | $479K |
| Losartan Potassium Generic | 174 | 196 | 32 | $421 |
| Vtama Tapinarof | 152 | 152 | 21 | $200K |
| Metoprolol Succinate Generic | 140 | 168 | 30 | $875 |
Brand drugs: 4,811 claims; generic drugs: 3,872 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marina Kurman $1,796 ($1,796 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $403.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $403 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 11 | $189 |
| Abbvie Inc. ABBV | 9 | $183 |
| Amgen Inc. AMGN | 8 | $167 |
| Sumitomo Pharma America, Inc. 4506.T | 11 | $160 |
| Axsome Therapeutics, Inc. AXSM | 7 | $148 |
| Incyte Corporation INCY | 5 | $130 |
| Medtronic, Inc. MDT | 3 | $94.1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88.05 |
| Novo Nordisk Inc NVO | 2 | $55.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.